Ipca Laboratories Limited (NSE:IPCALAB)
India flag India · Delayed Price · Currency is INR
1,911.20
+11.10 (0.58%)
Aug 21, 2026, 3:30 PM IST

Ipca Laboratories Balance Sheet

Millions INR. Fiscal year is Apr - Mar.

Assets

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash & Equivalents
-4,3711,6722,08912,5792,752
Short-Term Investments
-1,2501,745851.35,9503,657
Trading Asset Securities
-6,3347,6345,5843,2337,193
Cash & Short-Term Investments
11,95611,95611,0518,52421,76113,602
Cash Growth
8.19%8.19%29.63%-60.83%59.98%79.24%
Accounts Receivable
-20,14318,84116,9469,9619,180
Other Receivables
-2,0542,5682,0121,8652,088
Receivables
-22,69521,83719,05211,85911,372
Inventory
-27,31025,60424,71317,43418,580
Prepaid Expenses
-620.3573.1482.9311.9188.6
Other Current Assets
-1,1883,6202,617527.1829.7
Total Current Assets
-63,76962,68555,38951,89344,572
Property, Plant & Equipment
-52,02246,85146,63126,94625,026
Long-Term Investments
-2,1012,1633,0363,0272,699
Goodwill
-828.1905.8905.8381.4388.4
Other Intangible Assets
-1,1481,1271,4261,5911,672
Long-Term Deferred Tax Assets
-205.4169.242.335.720.2
Other Long-Term Assets
-3,4843,3812,6971,2321,144
Total Assets
-123,702117,606111,01386,26476,235

Liabilities

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Accounts Payable
-9,4038,4627,7615,2515,577
Accrued Expenses
-3,4213,2163,8002,0512,278
Short-Term Debt
-4,1754,9535,5926,6183,678
Current Portion of Long-Term Debt
-1,7732,6322,4791,439282.5
Current Portion of Leases
-179.3101.4109.366.644.8
Current Income Taxes Payable
-686.6575462253.2183.3
Current Unearned Revenue
-191.2154.7168.7274267.7
Other Current Liabilities
-3,2403,7693,1842,1052,347
Total Current Liabilities
-23,06923,86223,55618,05814,659
Long-Term Debt
-1,0915,4325,8046,5183,952
Long-Term Leases
-868.9509399.3170.8115
Long-Term Unearned Revenue
---1.22.84.3
Pension & Post-Retirement Benefits
-71.4119.589.716.713.9
Long-Term Deferred Tax Liabilities
-2,4492,9503,1051,8921,644
Other Long-Term Liabilities
-911.9850787.4453.2430.1
Total Liabilities
-28,46133,72333,74327,11120,818

Shareholders' Equity

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Common Stock
-253.7253.7253.7253.7253.7
Additional Paid-In Capital
-965.2965.2965.2965.2965.2
Retained Earnings
-79,47368,42462,10457,15153,471
Comprehensive Income & Other
--53.7-158.2-150.7-41.6
Total Common Equity
80,63880,63869,48563,32258,42054,648
Minority Interest
-14,60314,39813,948733769.2
Shareholders' Equity
95,24195,24183,88377,27059,15355,418
Total Liabilities & Equity
-123,702117,606111,01386,26476,235

Additional Metrics

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Total Debt
8,0888,08813,62714,38414,8138,072
Net Cash (Debt)
3,8683,868-2,577-5,8596,9495,530
Net Cash Growth
----25.65%12.06%
Net Cash Per Share
15.2515.25-10.16-23.0927.3921.80
Filing Date Shares Outstanding
253.72253.7253.7253.7253.7253.7
Total Common Shares Outstanding
253.72253.7253.7253.7253.7253.7
Working Capital
-40,69938,82331,83333,83529,913
Book Value Per Share
317.84317.84273.88249.59230.27215.40
Tangible Book Value
78,66278,66267,45260,99056,44852,588
Tangible Book Value Per Share
310.06310.06265.87240.40222.49207.28
Land
-3,1593,0756,4252,1452,157
Buildings
-15,58514,43213,5698,1757,140
Machinery
-51,91746,68743,73729,45424,473
Construction In Progress
-7,6166,1623,2361,2222,939
Leasehold Improvements
-17.212.8-7.9-